Akebia Therapeutics reported $0 in Loan Capital for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Loan Capital Change
Alnylam Pharmaceuticals ALNY:US USD 1.02B 967K
Amgen AMGN:US USD 37.35B 193M
Astellas Pharma 4503:JP JPY 148.74B 66.35B
AstraZeneca AZN:LN USD 23.69B 9M
Avrobio Inc AVRO:US USD 15.2M 101K
Bayer BAYN:GR EUR 33.79B 5.67B
Biomarin Pharmaceutical BMRN:US USD 1.08B 1.17M
GlaxoSmithKline GSK:LN GBP 17.04B 2.29B
Intercept Pharmaceuticals ICPT:US USD 223.1M 248K
Ironwood Pharmaceuticals IRWD:US USD 396.25M 401K
Karyopharm Therapeutics KPTI:US USD 302.82M 69K
Lexicon Pharmaceuticals LXRX:US USD 48.58M 24.8M
Moderna Inc MRNA:US USD 912M 10M
Opko Health OPK:US USD 210.4M 55.26M
Ptc Therapeutics PTCT:US USD 1.28B 294.53M
Regeneron Pharmaceuticals REGN:US USD 2.7B 300K
Roche Holding ROG:VX 21.39B 978M
Sarepta Therapeutics SRPT:US USD 1.54B 1.52M